Tanya L Hoskin

6PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)MechanobiologyEnvironmental epidemiologyCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 28, 2025
Reply to: "Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer" and "CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer".

Matthew P Goetz, Grace M Choong, Tanya L Hoskin

|Aug 17, 2025
High-resolution microCT to assess breast microcalcification morphometry by histologic lesion subtype and radiologic classification.

Sarah Schrup, Santo Maimone, Michael Villalba

|Apr 11, 2025
Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast Cancer.

Grace M Choong, Tanya L Hoskin, Judy C Boughey

|Jan 09, 2025
Changes in breast cancer risk associated with benign breast disease from 1967 to 2013.

Amy C Degnim, Karthik Ghosh, Robert A Vierkant

|May 24, 2023
Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast.

Amy C Degnim, Brittany L Siontis, Safia K Ahmed

|Jun 02, 2022
Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031).

Vera J Suman, Lili Du, Tanya Hoskin

Pageof 1